Glycanostics receives prestigious EIC Accelerator grant
Glycanostics has been selected as one of 65 innovative start-ups and SMEs out of more than 4,000 applicants to receive funding under the European Innovation Council (EIC) Accelerator scheme. Glycanostics became
Glycanostics was successful on Crowdberry Investment Platform
Another important milestone achieved by the Glycanostics team! Via the Crowdberry Investment Platform, we presented our highly accurate diagnostic test to private investors in September 2021 and raised an additional
Glycanostics meets the President of the EC, Ms. Ursula von der Leyen
On Monday 21st June , our CEO Eva Kováčová (on the right) together with CSO Jan Tkac (on the left) had the great honour to introduce the company Glycanostics to the President of the EC,
Important step for Glycanostics with CBIM
Glycanostics and Crowdberry Investment Management took an important step towards achieving its vision. On Friday 7th May 2021 we signed an investment agreement to gain key resources of €310,000 for
A HIGHLY-PRESTIGIOUS AWARD FOR A GLYCANOSTICS CO-FOUNDER
This year, a well-established IT company from Slovakia ESET launched a prestigious ESET Science Award for exceptional scientists to increase the popularity of excellent scientists. Among all the scientists nominated,
INTERNATIONAL PATENT APPLICATION NO. PCT/EP2019/057386
On 3rdOctober 2019, PCT application titled “Means and methods for glycoprofiling of aprotein” (applicant Glycanostics, inventors Tomas Bertok and Jan Tkac) waspublished under publication number WO 2019/185515. This patent applicationcovers the
GLYCANOSTICS WINS NATIONAL ROUND OF CENTRAL EUROPEAN STARTUP AWARDS
With the unique, glycan-based technology and possible benefits forpatients, clinicians and society, Glycanostics was announced as a CESA awardwinner in two independent categories – Best Health-Tech Startup and Best SocialImpact
GLYCANOSTICS WINS HORIZON 2020 GRANT
After receiving the prestigious “Seal of Excellence” from the European Commission on October 23, 2018, Glycanostics’ next submission, to the Horizon 2020 Programme, won a € 50 000 grant. The Horizon 2020 Programme
GLYCANOSTICS RECEIVES THE PRESTIGIOUS HORIZON 2020 “SEAL OF EXCELLENCE”
The European Commission awarded Glycanostics the prestigious Seal of Excellence for its revolutionary prostate cancer early diagnostic tests. This project was submitted under the Horizon 2020 Programme for Research and Innovation 2014-2020,
GLYCANOSTICS WINS TOP-6 BEST STARTUPS IN CENTRAL EUROPE
The FutureNow startup competition, also known as the Startup Awards, is akin to the Oscars for the best startups with global potential. This year marked the eighth and largest occurrence
GLYCANOSTICS SUCCESFULLY FINISHED HORIZON 2020 SME INSTRUMENT 1 GRANT
In august 2019, Glycanostics successfully finished the first phase of SME Instrument, by finishing a feasibility study and a business plan with the help from advisors and a consultation agency.
GLYCANOSTICS WINS THE EUROPEAN RESEARCH COUNCIL GRANT
Glycanostics innovations are again supported and highly ranked by leading industry experts. This time the company won the European Research Council (ERC) Proof of Concept Grant. The ERC president Jean Pierre
